natgillin/translations-raw huggingface dataset:
You must take Renvela as prescribed by your doctor.
Pri jemanju zdravila Renvela natančno upoštevajte navodila svojega zdravnika.
Renvela is also indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease (CKD) not on dialysis with serum phosphorus ≥ 1.78 mmol/l.
Zdravilo Renvela je indicirano tudi za nadzor hiperfosfatemije pri odraslih bolnikih s kronično boleznijo ledvic (KBL; CKD - Chronic Kidney Disease), ki niso na dializi, in imajo raven fosforja v serumu ≥ 1,78 mmol/l.
The oral suspension must be administered within 30 minutes.
Po rekonstituciji Peroralno suspenzijo je treba uporabiti v 30 minutah.
Your doctor should monitor the level of bicarbonate in your blood.
Zdravnik vam mora kontrolirati koncentracijo bikarbonata v krvi.
The medicinal product does not require any special storage conditions.
Za shranjevanje zdravila niso potrebna posebna navodila.
Powder for oral suspension 0.8 g powder
prašek za peroralno suspenzijo 0,8 g praška
Each sachet of 0.8 g of powder is to be dispersed in 30 mL of water prior to administration (see section 6.6).
Vsako vrečico po 0,8 g praška je treba pred uporabo raztopiti v 30 ml vode (glejte poglavje 6.6).
Sevelamer has been shown to bind bile acids in vitro and in vivo in experimental animal models.
Pri živalskih modelih se je pokazalo, da sevelamer veže žolčne kisline in vitro in in vivo.
Hepatic impairment No studies have been performed in patients with hepatic impairment.
Okvara jeter Študij pri bolnikih z okvaro jeter niso izvedli.
60 sachets per carton 90 sachets per carton
Velikosti pakiranja: 60 vrečic na škatlo 90 vrečic na škatlo
Packs of 1 bottle of 30 or 180 tablets (without outer carton) and a multipack containing 180 (6 bottles of 30) tablets.
Pakiranja z 1 vsebnikom, ki vsebuje 30 ali 180 tablet (brez zunanje škatle), in skupno pakiranje s 180 (6 vsebnikov po 30 tablet) tabletami.
Powder for oral suspension 1.6 g powder
prašek za peroralno suspenzijo 1,6 g praška
Renvela is unlikely to affect your ability to drive or to use machines.
Vpliv na sposobnost upravljanja vozil in strojev Ni verjetno, da bi zdravilo Renvela vplivalo na vašo sposobnost vožnje in upravljanja strojev.
Each sachet of 1.6 g of powder is to be dispersed in 40 mL of water prior to administration (see section 6.6).
Vsako vrečico po 1,6 g praška je treba pred uporabo raztopiti v 40 ml vode (glejte poglavje 6.6).
- Serious inflammation of the large bowel (symptoms include: severe abdominal pain, stomach or intestine disorders, or blood in the stool [gastrointestinal bleeding]) and crystal deposit in the intestine have been reported.
- Poročali so o resnem vnetju debelega črevesa (med simptomi so: hude bolečine v trebuhu, težave z želodcem ali črevesom ali kri v blatu [krvavitev v prebavila]) in kristalnih depozitih v črevesu.
Total daily dose of sevelamer carbonate to be taken over 3 meals/snacks per day
Skupni dnevni odmerek sevelamerijevega karbonata vzetskupaj s 3 obroki/prigrizki na dan
In two randomised, cross over clinical trials, sevelamer carbonate has been shown to be therapeutically equivalent to sevelamer hydrochloride and therefore effective in controlling serum phosphorus in CKD patients on haemodialysis.
V dveh randomiziranih, navzkrižnih kliničnih študijah se sevelamerijev karbonat pokazal kot terapevtsko enakovreden sevelamerijevemu kloridu in zato učinkovit pri nadziranju fosforja v serumu pri bolnikih s KBL na hemodializi.
Powder for oral suspension 2.4 g powder
prašek za peroralno suspenzijo 2,4 g praška
They will base the dose on your serum phosphorus level.
Zdravnik bo odmerek določil glede na koncentracijo fosfata v serumu.
Deficits in skeletal ossification were observed in several locations in foetuses of female rats dosed with sevelamer at intermediate and high doses (human equivalent dose less than the maximum clinical trial dose of 14.4 g).
Primanjkljaje skeletne osifikacije so opazili na več mestih pri plod podganjih samic, ki so prejemale srednje in visoke odmerke sevelamera (pri človeku primerljivo z odmerkom, manjšim od največjega odmerka v kliničnem preskušanju, ki je 14,4 g).
What you need to know before you take Renvela Do not take Renvela if:
Kaj morate vedeti, preden boste vzeli zdravilo Renvela
Excipients This medicine contains less than 1 mmol sodium (23 mg) per tablet that is to say essentially ‘sodium-free'.
Pomožne snovi To zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na tableto, kar v bistvu pomeni "brez natrija".
Each sachet of 2.4 g of powder is to be dispersed in 60 mL of water prior to administration (see section 6.6).
Vsako vrečico po 2,4 g praška je treba pred uporabo raztopiti v 60 ml vode (glejte poglavje 6.6).
0.8 g three times daily Titrate up/down by 0.4 g three times daily 1.6 g three times daily Titrate up/down by 0.8 g three times daily
Titrirajte s povečanjem/zmanjšanjem za 0,8 g trikrat na dan
Very rare cases of hypothyroidism have been reported in patients co-administered with sevelamer hydrochloride, which contains the same active moiety as sevelamer carbonate, and levothyroxine.
Poročali so o zelo redkih primerih hipotiroidizma pri bolnikih, ki so sočasno prejemali sevelamerijev klorid, ki vsebuje enako učinkovino kot sevelamerijev karbonat, in levotiroksin.
• dysphagia
• disfagija
For a 0.8 g dose, the powder for oral suspension should be dispersed in 30 mL of water per sachet.
0,8 g praška za peroralno suspenzijo raztopite v 30 ml vode na vrečico.
This medicine does not require any special storage conditions.
Za shranjevanje zdravila niso potrebna posebna navodila
If a dose of 0.4 g is to be administered, please use the dedicated 0.8 g powder presentation with dosing spoon.
Če je potrebno zaužiti 0,4 g odmerek, prosimo uporabite temu namenjeno 0,8 g obliko praška z odmerno žličko.
Hyperparathyroidism
Hiperparatiroidizem
EU/1/09/521/008 90 sachets EU/1/09/521/009 90 sachets (with a dosing spoon)
EU/1/09/521/008 90 vrečic EU/1/09/521/009 90 vrečic (z odmerno žličko)
PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING LABEL - BOTTLE OF 30 TABLETS (WITH OUTER CARTON) LABEL with Blue box - BOTTLE OF 180 TABLETS (WITHOUT OUTER CARTON)
OZNAKA - VSEBNIK S 30 TABLETAMI (Z ZUNANJO ŠKATLO) OZNAKA s podatki za modro okence - VSEBNIK S 180 TABLETAMI (BREZ ZUNANJE ŠKATLE VKLJUČNO Z BLUE BOX)
Closer monitoring of thyroid stimulating hormone (TSH) levels is therefore recommended in patients receiving sevelamer carbonate and levothyroxine.
Zato se pri bolnikih, ki dobivajo sevelamerijev karbonat in levotiroksin priporoča skrbno nadziranje ravni ščitnico stimulirajočega hormona (thyroid stimulating hormone - TSH).
There was an increased incidence of urinary bladder transitional cell papilloma in male rats of the high dose group (human equivalent dose twice the maximum clinical trial dose of 14.4 g).
Opazili so večjo pojavnost papiloma tranzicijskih celic mehurja pri podganjih samcih v skupini z visokimi odmerki (pri človeku primerljivo z odmerkom, dvakrat večjim od največjega odmerka v kliničnem preskušanju, ki je 14,4 g).
Regular monitoring of serum phosphorus levels is always necessary during phosphate binder administration.
V času odmerjanja vezalcev fosfata je vedno treba redno nadzirati ravni fosfata v serumu.
If you get any of the following side effects, seek immediate medical attention:
Nemudoma poiščite zdravniško pomoč, če se vam pojavi kateri od naslednjih neželenih učinkov:
Renvela contains sevelamer carbonate as the active substance.
Zdravilo Renvela vsebuje učinkovino sevelamerijev karbonat.
Swallowing and choking difficulties
Težave s požiranjem in dušenjem
Inflammatory disorders may resolve upon sevelamer discontinuation.
Vnetne motnje lahko po prenehanju uporabe sevelamerja minejo.
- The active substance is sevelamer carbonate.
- Učinkovina je sevelamerijev karbonat.
Renvela 1.6 g powder for oral suspension
Renvela 1,6 g prašek za peroralno suspenzijo
In two randomised, cross over clinical trials, sevelamer carbonate in both tablet and powder formulations when administered three times per day has been shown to be therapeutically equivalent to sevelamer hydrochloride and therefore effective in controlling serum phosphorus in CKD patients on haemodialysis.
V dveh randomiziranih, navzkrižnih kliničnih študijah se je sevelamerijev karbonat tako v obliki tablete kot tudi praška, pokazal kot terapevtsko enakovreden sevelamerijevemu kloridu in zato učinkovit pri nadziranju fosforja v serumu pri bolnikih s KBL na hemodializi.
For a 2.4 g dose, the powder for oral suspension should be dispersed in 60 mL of water per sachet.
2,4 g praška za peroralno suspenzijo raztopite v 60 ml vode na vrečico.
PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING LABEL - BOTTLE OF 30 TABLETS (MULTIPACK PRESENTATION)
OZNAKA - VSEBNIK S 30 TABLETAMI (SKUPNO PAKIRANJE)
Excipients This medicine contains less than 1 mmol sodium (23 mg) per sachet that is to say essentially ‘sodium-free'.
Pomožne snovi To zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na vrečico, kar v bistvu pomeni "brez natrija".
• active inflammation of the bowel
• aktivno vnetje črevesja
Discard the sachet after 24 hours of opening.
Zavrzite vrečico v roku 24 ur po odprtju.
For a 1.6 g dose, the powder for oral suspension should be dispersed in 40 mL of water per sachet.
1,6 g praška za peroralno suspenzijo raztopite v 40 ml vode na vrečico.
BSA (m2)
Telesna površina (m
Renvela should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy Vitamin D3 or one of its analogues to control the development of renal bone disease.
Zdravilo Renvela je treba uporabljati v smislu večstranskega pristopa zdravljenja, ki lahko vključuje dodatek kalcija, 1,25-dihidroksi vitamin D3 ali kakšen njegov analog, za nadziranje razvoja renalne osteodistrofije.
(Instructions for presentation with dosing spoon)
(Navodila za obliko z odmerno žličko)
Talk to your doctor while taking Renvela:
Med jemanjem zdravila Renvela se posvetujte z zdravnikom:
- The other ingredients are propylene glycol alginate (E405), citrus cream flavour, sodium chloride,
- Pomožne snovi so propilenglikol alginat (E405), aroma citrusove kreme, natrijev klorid, sukraloza in rumeni železov oksid (E172).
Total daily dose of sevelamer carbonate to be taken over 3 meals per day
Skupni dnevni odmerek sevelamerijevega karbonata, vzet skupaj s 3 obroki na dan
The treatment should be re-evaluated in patients who develop severe constipation or other severe gastrointestinal symptoms.
Pri bolnikih, ki imajo hudo zaprtje ali druge hude gastrointestinalne simptome, je treba ponovno pretehtati smiselnost zdravljenja.
Renvela 2.4 g powder for oral suspension
Renvela 2,4 g prašek za peroralno suspenzijo
Each sachet contains 0.8 g sevelamer carbonate.
Vsaka vrečica vsebuje 0,8 g sevelamerijevega karbonata.
In the event of a possible overdose you should contact your doctor immediately.
Če ste vzeli večji odmerek zdravila Renvela, kot bi smeli V primeru prevelikega odmerka se takoj posvetujte z zdravnikom.
The treatment response was maintained in the paediatric patients who received sevelamer carbonate during the 6month open-label DTP.
Pri pediatričnih bolnikih, ki so sevelamerijev karbonat prejemali med 6-mesečnim OTO z odprtim načrtom zdravljenja, se je odziv na zdravljenje ohranil.
Non-clinical data with sevelamer reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity or genotoxicity.
Predklinični podatki na osnovi običajnih študij farmakološke varnosti, toksičnosti pri ponavljajočih se odmerkih in genotoksičnosti s sevelamerom ne kažejo posebnega tveganja za človeka.
How to store Renvela
Shranjevanje zdravila Renvela
Renvela 0.8 g powder for oral suspension
Renvela 0,8 g prašek za peroralno suspenzijo
Each sachet contains 1.6 g sevelamer carbonate.
Vsaka vrečica vsebuje 1,6 g sevelamerijevega karbonata.
Each sachet contains 2.4 g sevelamer carbonate.
Vsaka vrečica vsebuje 2,4 g sevelamerijevega karbonata.
Inflammatory gastrointestinal disorders
Zaviralci protonske črpalke
Talk to you doctor before taking Renvela if any of the following applies to you:
Opozorila in previdnostni ukrepi Če karkoli od naslednjega velja za vas, se pred začetkom jemanja zdravila Renvela posvetujte s svojim zdravnikom:
o Fill the powder to the spoon level.
o Vsujte prašek v odmerno žličko.
Renvela 1.6 g powder for oral suspension sevelamer carbonate
Renvela 1,6 g prašek za peroralno suspenzijo sevelamerijev karbonat
The powder should be dispersed in 60 mL of water per sachet prior to administration.
Prašek je treba pred uporabo raztopiti v 60 ml vode na vrečico.
Serum phosphorus levels must be monitored and the dose of sevelamer carbonate titrated by 0.8 g three times per day (2.4 g/day) increments every 2-4 weeks until an acceptable serum phosphorus level is reached, with regular monitoring thereafter.
Ravni fosforja v serumu je treba nadzirati in odmerek sevelamerijevega karbonata titrirati z 0,8 g odmerkom trikrat na dan (2,4 g/dan) vsake 2-4 tedne, dokler ni dosežena sprejemljiva raven fosforja v serumu.
The powder should be dispersed in 30 mL of water per sachet prior to administration.
Prašek je treba pred uporabo raztopiti v 30 ml vode na vrečico.
Renvela 0.8 g powder for oral suspension sevelamer carbonate
Renvela 0,8 g prašek za peroralno suspenzijo sevelamerijev karbonat
Each film-coated tablet contains 800 mg of sevelamer carbonate - The other ingredients are microcrystalline cellulose, sodium chloride and zinc stearate.
- Pomožne snovi so mikrokristalna celuloza, natrijev klorid in cinkov stearat.
Renvela 2.4 g powder for oral suspension sevelamer carbonate
Renvela 2,4 g prašek za peroralno suspenzijo sevelamerijev karbonat
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON with Blue Box - MULTIPACK OF 180 (6 BOTTLES OF 30) TABLETS
ŠKATLA s podatki za modro okence - SKUPNO PAKIRANJE S 180 (6 VSEBNIKOV PO 30) TABLETAMI
Propylene glycol alginate (E405) Citrus cream flavour Sodium chloride Sucralose
6.1 Seznam pomožnih snovi propilenglikol alginat (E405) aroma citrusove kreme natrijev klorid sukraloza rumeni železov oksid (E172)
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON with Blue box - BOTTLE OF 30 TABLETS
ŠKATLA s podatki za modro okence - VSEBNIK S 30 TABLETAMI
- Rupture in the intestinal wall (signs include: severe stomach pain, chills, fever, nausea, vomiting, or a tender abdomen) has been reported.
- Poročali so predrtju črevesne stene (med znaki so hude bolečine v trebuhu, mrzlica, zvišana telesna temperatura, slabost v želodcu (siljenje na bruhanje), bruhanje ali občutljivost trebuha).
In patients with secondary hyperparathyroidism sevelamer carbonate should be used within the context of a multiple therapeutic approach, which could include calcium as supplements, 1,25-dihydroxy Vitamin D3 or one of its analogues to lower the intact parathyroid hormone (iPTH) levels.
Pri bolnikih s sekundarnim hiperparatiroidizmom je treba sevelamerijev karbonat uporabljati v smislu večstranskega pristopa zdravljenja, ki lahko vključuje kalcij kot dodatke, 1,25-dihidroksi vitamin D3 ali kakšen njegov analog za nižanje ravni intaktnega paratiroidnega hormona (iPTH).
In clinical practice, treatment will be continuous based on the need to control serum phosphorus levels and the daily dose is expected to be an average of approximately 6 g per day.
V klinični praksi je zdravljenje stalno glede na potrebo nadziranja ravni fosforja v serumu.
(Instructions for presentation WITHOUT dosing spoon) To achieve the correct dose when the sachet has to be divided, please use the dedicated presentation of 0.8 g powder with dosing spoon.
Za dosego ustreznega odmerka, ko je treba vrečico razdeliti, prosimo uporabite temu namenjeno 0,8 g obliko praška z odmerno žličko.
In patients with secondary hyperparathyroidism sevelamer carbonate should be used within the context of a multiple therapeutic approach, which could include calcium as supplements, 1,25-dihydroxy Vitamin D3 or one of its analogues to lower the iPTH levels.
Pri bolnikih s sekundarnim hiperparatiroidizmom je treba sevelamerijev karbonat uporabljati v smislu večstranskega pristopa zdravljenja, ki lahko vključuje dodatke kalcija, 1,25-dihidroksi vitamin D3 ali kakšen njegov analog za nižanje ravni iPTH.
The powder should be dispersed in 40 mL of water per sachet prior to administration.
Prašek je treba pred uporabo raztopiti v 40 ml vode na vrečico.
The use of sevelamer carbonate powder in patients with a history of difficulty swallowing should be considered.
Pri bolnikih z anamnezo težav s požiranjem razmislite o uporabi praška sevelamerijevega karbonata.
For adult patients, serum phosphorus levels must be monitored and the dose of sevelamer carbonate titrated by 0.8 g three times per day (2.4 g/day) increments every 2-4 weeks until an acceptable serum phosphorus level is reached, with regular monitoring thereafter.
Serumske ravni fosforja je treba pri odraslih redno nadzirati in odmerek sevelamerijevega karbonata titrirati z 0,8 g odmerkom trikrat na dan (2,4 g/dan) vsake 2-4 tedne, dokler ni dosežena sprejemljiva raven fosforja v serumu.
Caution should be exercised when prescribing PPI to patients concomitantly treated with Renvela.
Bolnikom, ki sočasno prejemajo zdravilo Renvela, je treba zaviralce protonske črpalke predpisovati previdno.
Excipients
Levotiroksin
Dialysis Interaction studies have not been conducted in patients on dialysis.
Dializa Pri bolnikih, ki se zdravijo s hemodializo, niso preučevali medsebojnega delovanja.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON - CARTON OF 60 or 90 SACHETS
ŠKATLA - ŠKATLA S 60 ALI 90 VREČICAMI
PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING LABEL - SACHETS
OZNAKA - VREČICE
Organ Class
KLINIČNI PODATKI
o Ensure the dosing spoon is dry o Hold the dosing spoon horizontally and pour the powder out of the sachet into the dosing spoon.
o Odmerno žličko držite vodoravno in vsipajte prašek iz vrečice na odmerno žličko.
intestinal mass*1
masa v črevesu*
- Blockage in the intestine (signs include: severe bloating; abdominal pain, swelling or cramps; severe constipation) has been reported.
- Poročali so o zapori črevesa (med znaki so hudo napenjanje, bolečine v trebuhu, otekanje ali krči, huda zaprtost).
Powder for oral suspension.
prašek za peroralno suspenzijo Svetlorumeni prašek.
This summary was last updated in December 2019.
Ta povzetek je bil nazadnje posodobljen decembra 2019.
The studies showed the vaccine to be effective in reducing death.
Študije so pokazale, da je cepivo učinkovito pri zmanjševanju števila poginov.
Further information on Eravac can be found on the Agency's website: ema.europa.eu/medicines/veterinary/EPAR/eravac.
Nadaljnje informacije o zdravilu Eravac so na voljo na spletni strani agencije: ema.europa.eu/medicines/veterinary/EPAR/eravac.
Protection starts one week after vaccination and lasts 12 months.
Zaščita se vzpostavi en teden po cepljenju in traja 12 mesecev.
It is usually a fatal disease resulting in the formation of blood clots.
Običajno gre za smrtno bolezen, ki povzroča nastajanje krvnih strdkov.
What is Eravac and what is it used for?
Kaj je zdravilo Eravac in za kaj se uporablja?
Eravac is a vaccine.
Zdravilo Eravac je cepivo.
The European Medicines Agency decided that Eravac's benefits are greater than its risks and that it can be authorised for use in the EU.
Evropska agencija za zdravila je zaključila, da so koristi cepiva Eravac večje od z njim povezanih tveganj in da se lahko odobri za uporabo v EU.
Eravac received a marketing authorisation valid throughout the EU for Eravac on 22 September 2016.
Zdravilo Eravac je pridobilo dovoljenje za promet, veljavno po vsej Evropski uniji 22. septembra 2016.
What benefits of Eravac have been shown in studies?
Kakšne koristi je zdravilo Eravac izkazalo v študijah?
Why is Eravac approved in the EU?
Zakaj je bilo zdravilo Eravac odobreno v EU?
Rabbits should be revaccinated one year after vaccination.
Kunce bi bilo treba ponovno cepiti eno leto po prvem cepljenju.
The slight temperature increase resolves spontaneously without treatment within 5 days and the local reactions resolve spontaneously within 24 hours.
Blažji dvig telesne temperature izzveni samodejno brez zdravljenja v petih dneh, lokalne reakcije pa v 24 urah.
An overview of Eravac and why it is authorised in the EU
Pregled zdravila Eravac in zakaj je odobreno v EU
What are the risks associated with Eravac?
Kakšna tveganja so povezana z zdravilom Eravac?
The effectiveness of the vaccine was initially compared with that of a placebo (dummy) vaccine in three laboratory studies involving 301 rabbits.
Učinkovitost cepiva so najprej primerjali z učinkovitostjo placeba (cepiva brez učinkovine) v treh laboratorijskih študijah, ki so vključevale 301 kunca.
The most common side effects with Eravac (which may affect more than 1 in 10 rabbits) are a shortlived increase in body temperature to slightly above 40 ºC, which may occur between two or three days after vaccination, and nodules or swellings (less than 2 cm in size) at the injection site.
Najpogostejši neželeni učinki zdravila Eravac (ki lahko prizadenejo več kot 1 od 10 kuncev) so kratkotrajno zvišanje telesne temperature na nekoliko nad 40 °C, kar se lahko pojavi po dveh do treh dneh po cepljenju, ter vozliči ali otekline (velikosti manj kot 2 cm) na mestu injiciranja.
In the future if rabbits come into contact with rabbit haemorrhagic disease type 2 virus, these antibodies, together with other components of the immune system, will be able to destroy the virus and help protect against the disease.
Če bodo kunci v prihodnosti prišli v stik z virusom hemoragične bolezni kuncev tipa 2, bodo lahko ta protitelesa skupaj z drugimi mehanizmi imunskega sistema uničila virus in pripomogla k zaščiti pred boleznijo.
RHD type 2 virus differs from the classic form of RHD virus since the course of disease is more prolonged, death occurs later and over a longer period and is more severe in young rabbits.
Virus RHD tipa 2 se razlikuje od klasične oblike virusa RHD, saj je bolezen dolgotrajnejša, pogin se pojavi pozneje in v daljšem časovnem obdobju, najhujše pa prizadene mlajše kunce.
Eravac contains an adjuvant (mineral oil) to enhance the immune response.
Zdravilo Eravac vsebuje adjuvans (mineralno olje), ki spodbuja imunski odziv.
The withdrawal period for meat from rabbits treated with Eravac for is ‘zero' days, which means there is no mandatory waiting time.
Karenca za meso kuncev, zdravljenih z zdravilom Eravac, je nič dni, kar pomeni, da ni obvezne čakalne dobe.
When it is given to rabbits, the immune system recognises the virus in the vaccine as ‘foreign' and makes antibodies against it.
Ko kunci prejmejo cepivo, imunski sistem prepozna virus v cepivu kot „tujek“ in začne proti njemu tvoriti protitelesa.
After vaccination the rabbits were artificially infected with RHDV2.
Po cepljenju so bili kunci umetno okuženi z virusom RHDV2.
The vaccine is given to rabbits from 30 days of age as a single injection under the skin of the side of the chest.
Daje se kuncem, starejšim od 30 dni, kot enkratna injekcija pod kožo v bočni del prsnega koša.
Other information about Eravac?
Druge informacije o zdravilu Eravac
How is Eravac used?
Kako se zdravilo Eravac uporablja?
Eravac is a veterinary vaccine used in rabbits to reduce death due to the rabbit haemorrhagic disease (RHD), caused by the variant of RHD virus called RHD type 2 (RHDV2).
Eravac je cepivo za uporabo v veterinarski medicini, ki se uporablja pri kuncih za zmanjševanje poginov zaradi hemoragične bolezni kuncev (RHD), ki jo povzroča različica virusa RHD, imenovana virus RHD tipa 2 (RHDV2).
Eravac is available as an injection and can only be obtained with a prescription.
Cepivo Eravac je na voljo v obliki injekcije, njegovo predpisovanje in izdaja pa je le na recept.
Eravac contains rabbit haemorrhagic disease type 2 virus (RHDV2) strain V-1037, which has been inactivated so it cannot cause the disease.
Zdravilo Eravac vsebuje virus hemoragične bolezni kuncev tipa 2 (RHDV2), sev V-1037, ki je bil inaktiviran, tako da ne povzroča bolezni.